Pomegra
From $115 to $185: A Pricing Roadshow That Rewrote the Record Books
The Cerebras IPO roadshow was a study in accelerating demand. When the company first launched its offering on May 4, management targeted 28 million shares at $115 to $125 per share. Within days, overwhelming investor appetite forced an upsize — shares on offer increased to 30 million and the price range jumped to $150–$160. Final pricing at $185 represents a 61% premium over the original midpoint, a testament to the ferocity of institutional demand. Underwriters, led by Morgan Stanley, Citigroup, Barclays, and UBS, hold an overallotment option on an additional 4.5 million shares.
- Cerebras (CBRS) priced at $185/share, above the $150–$160 range, raising $5.55 billion — the largest U.S. IPO of 2026 so far.
- CBRS shares were indicated to open approximately 90% above the IPO price on their first trading day, May 14, 2026.
- Revenue surged 76% year-over-year to $510 million in 2025, with a $20 billion OpenAI compute partnership signed in January 2026.
The book was reportedly oversubscribed more than 20 times, a level of demand rarely seen in technology IPOs even during the most frenzied market cycles. On the morning of the first trading day, CBRS shares were indicated to open approximately 90% above the $185 IPO price, pointing to a potential opening near $350 per share on the Nasdaq floor.
Wafer-Scale Architecture: The Technology Behind the Valuation
Founded in 2015 by CEO Andrew Feldman, Cerebras built its identity on a single, audacious engineering thesis: instead of clustering thousands of small GPU chips to power AI inference, design one massive Wafer Scale Engine — roughly the size of a dinner plate — that integrates hundreds of thousands of compute cores onto a single processor. The WSE-3 chip, Cerebras' current flagship, is positioned to deliver speed and cost advantages over conventional Nvidia GPU clusters, particularly for AI inference workloads where latency matters most.
The architecture drew the attention of some of the world's largest AI infrastructure builders. In January 2026, Cerebras signed a landmark deal with OpenAI valued at over $20 billion, covering 750 megawatts of Cerebras computing capacity — one of the largest supply agreements in the history of the semiconductor industry. Additional customers now include Amazon Web Services, Meta, and IBM, a significant broadening from the company's earlier customer concentration.
Resolving the G42 Overhang
Cerebras' path to the Nasdaq was not linear. The company first filed publicly for an IPO in September 2024 but withdrew its prospectus a year later after the Committee on Foreign Investment in the United States (CFIUS) launched a national security review tied to its heavy reliance on G42, a UAE-based AI company that accounted for 85% of revenue in 2024. That review ultimately cleared the deal, but the episode forced a strategic transformation.
By the time Cerebras refiled its S-1 registration statement with the SEC in April 2026, the G42 revenue concentration had dropped to 24%, while the Mohamed bin Zayed University of Artificial Intelligence in the UAE accounted for 62% of 2025 revenue. The company simultaneously accelerated its shift toward a cloud services model, competing directly with Google Cloud, Microsoft Azure, Oracle, and CoreWeave in the AI infrastructure-as-a-service market. Bloomberg reported that Arm and SoftBank both made late-stage acquisition overtures to Cerebras in the weeks before the IPO, which the company declined to comment on.
Revenue Trajectory and Investor Composition
Cerebras reported $510 million in revenue for full-year 2025, representing 76% year-over-year growth from $290.3 million in 2024 — and a more than sixfold increase over two years, according to SEC filings. The company raised a total of $2.85 billion in equity and $1.85 billion in debt as a private company before turning to the public markets.
At the IPO price, CEO Andrew Feldman holds a stake valued at approximately $1.9 billion. Largest institutional shareholders include Fidelity (~$3.8 billion stake, 11.3% of Class B common stock), Benchmark (~$3.3 billion, 9.5%), Foundation Capital (~$2.8 billion, 8.3%), and Eclipse (~$2.5 billion, 7.3%). OpenAI CEO Sam Altman and co-founder Greg Brockman hold personal Cerebras stakes valued at roughly $16.5 million and $14.4 million, respectively, at IPO pricing.
Broader IPO Market: AI Reopens the Floodgates
Cerebras' debut arrives during a resurgent U.S. IPO market. Total U.S. IPO proceeds in 2026 have more than doubled versus the same period in 2025, reaching $22.3 billion, driven by artificial intelligence and defense sector listings, according to Dealogic. The Dow Jones U.S. Semiconductors Index has returned more than 107% over the past twelve months, compared with the S&P 500's roughly 26% gain.
Cerebras is widely viewed as the opening act of a broader AI IPO wave expected to peak later in 2026, with OpenAI, Anthropic, and SpaceX all publicly contemplating listings. The silicon renaissance, as market participants have termed the current semiconductor cycle, has lifted shares of Intel, AMD, and Micron each by more than 80% over the past month alone, reflecting broadening investor commitment well beyond Nvidia.
Market Outlook
Cerebras' explosive debut positions CBRS as an instant benchmark for the next generation of AI hardware companies. The combination of a validated wafer-scale chip architecture, a transformative OpenAI supply deal, rapidly diversifying revenues, and a proven management team has created one of the most compelling semiconductor public company narratives in a decade. With SpaceX's blockbuster offering expected in the summer of 2026, the broader AI IPO cycle is only gathering momentum — and Cerebras, now carrying a $56 billion-plus market capitalization, has set the standard for what that market is willing to pay.
Mentioned tickers: CBRS, NVDA, MSFT, GOOGL, AMD, INTC, MU, ARM, MS, C, BCS, UBS, SFTBY, SNOW, UBER, RIVN
